Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Cerilliant
UBS
US Department of Justice
Dow
Express Scripts
Daiichi Sankyo
Medtronic

Generated: July 22, 2018

DrugPatentWatch Database Preview

ONDANSETRON HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ondansetron Hydrochloride, and what generic alternatives are available?

Ondansetron Hydrochloride is a drug marketed by Accord Hlthcare, Apotex Inc, Aurobindo Pharma Ltd, Baxter Hlthcare Corp, Emcure Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Lannett Co Inc, Luitpold, Mylan Labs Ltd, Pliva Hrvatska Doo, Qilu Pharm Co Ltd, Sagent Pharms, Sandoz Inc, Sun Pharm Inds (in), Teva, West-ward Pharms Int, Wockhardt, Amneal Pharms, Apotex, Aurobindo Pharma, Taro, Casi Pharms Inc, Chartwell Molecules, Dr Reddys Labs Ltd, Glenmark Generics, Hikma Intl Pharms, Ipca Labs Ltd, Mylan, Natco Pharma Ltd, Emcure Pharms Ltd, Sun Pharm Inds Ltd, and Taro Pharms Ireland. and is included in sixty-eight NDAs.

The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Seventy-five suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Drug patent expirations by year for ONDANSETRON HYDROCHLORIDE
Pharmacology for ONDANSETRON HYDROCHLORIDE
Synonyms for ONDANSETRON HYDROCHLORIDE
1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-one hydrochloride
1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one hydrochloride
103639-04-9
110204-46-1
110707-92-1
4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, monohydrochloride
9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride
9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)-2,3-DIHYDRO-1H-CARBAZOL-4(9H)-ONE HYDROCHLORIDE
9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one monohydrochloride
9-METHYL-3-(2-METHYL-IMIDAZOL-1-YLMETHYL)-1,2,3,9-TETRAHYDRO-CARBAZOL-4-ONE HYDROCHLORIDE
9-methyl-3-[(2-methyl-1-imidazolyl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride
9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4h-carbazol-4-onhydrochlorid
9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one hydrochloride
9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one hydrochloride
99614-01-4
99614-02-5 (Parent)
A800774
AB0016622
AB07046
AB2000081
AC-12464
AC1L2A5S
AC1Q3ERO
AK321977
AKOS015889292
API0003688
BB_SC-1124
BC204680
BG0279
C18H19N3O.HCl
CCG-100852
CCG-221058
CHEMBL1201111
CPD000469179
CS-1715
CTK8F0270
Emeset
Emetron
GR 38032F HYDROCHLORIDE
GS-3597
H39O049
HMS1571C18
HY-B0002
I01-1935
I06-0131
I06-131
LS-51879
MFCD00833882
MKBLHFILKIKSQM-UHFFFAOYSA-N
MLS001304076
MLS001401397
MLS002222312
MolPort-003-983-448
NC00102
NSC 665799
NSC-665799
NSC665799
O0407
O739
Ondansetron (Hydrochloride)
ONDANSETRON HCl
Ondansetron hydrochloride (Zofran)
Ondansetron hydrochloride and dextrose in plastic container
Ondansetron hydrochloride and sodium chloride in plastic container
Ondansetron hydrochloride preservative free
Ondansetron hydrochloride, 98%
Ondemet
Ondemet;Emeset;Emetron;Zofran
OSETRON HYDROCHLORIDE
PubChem17490
Q-201515
REGID_for_CID_68647
RT-014862
s1390
SAM001246631
SCHEMBL41455
SMR000469179
SN 307
SN 307 HYDROCHLORIDE
TL8000158
VU0424014-2
Zofran
Zofran and dextrose in plastic container
ZOFRAN PRESERVATIVE FREE

US Patents and Regulatory Information for ONDANSETRON HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 076252-003 Jun 25, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Casi Pharms Inc ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride TABLET;ORAL 077517-003 Jun 25, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Taro ONDANSETRON HYDROCHLORIDE ondansetron hydrochloride SOLUTION;ORAL 077009-001 Nov 30, 2007 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE ondansetron hydrochloride INJECTABLE;INJECTION 078244-001 Apr 23, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Covington
Fish and Richardson
UBS
Chubb
Teva
Harvard Business School
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.